recent post

4th Edition of the Global Bio India 2024 paves way for future of biotech

September 13, 2024
recent post

France-based Dagard eyes India growth

recent post

Human Biogenesis raises pre-seed investment from Campus Fund

recent post

Novotech appoints Dr Yooni Kim as Executive Position of Managing Director for APAC

recent post

IIL signs MoA with ICMR for clinical development of Zika vaccine

September 12, 2024
imt Logo cross btn

AIMED applauds Delhi Govt’s draft policy to regulate private hospitals

AIMED applauds Delhi Govt’s draft policy to regulate private hospitals

Mr. Rajiv Nath, Forum Coordinator of Association of Indian Medical Device Industry (AiMeD)  said "We applaud the steps taken by Delhi Govt to lower the costs of treatment and bring more transparency and accountability to private healthcare services in Delhi and NCR. “If hospitals don't follow this advisory to discipline them it will lead to full blown regulations. The ethical hospitals will embrace the prescribed system, the unethical will continue till they are caught red handed and will state they are legally ok. How long can they escape legal regulatory scrutiny?” Added Mr. Nath. The move to clamp down on the private hospitals comes after the state government had appointed a  nine-member committee five months ago to suggest the scope of profit margins on medicines and consumables. The committee comprised of members of Delhi Medical Council, Indian Medical Association and some bureaucrats in the health department. It was then reported that Delhi government will issue a policy based on the recommendation of the committee in next few days. The Delhi Govt. on Monday, 28th May 2018 issued the draft advisory that the price of medicines and consumables could be upto a maximum of 50 per cent more than the purchase price, or it could be the MRP, whichever is lower. Delhi Government shows the way to other State Government and sets precedence, Central Govt should take the cue and expedite Revision of DPCO and Trade Margins Rationalisation - Rajiv Nath | Forum Coordinator | AiMeD "This will result in consumers access to medical devices at prices below inflated MRP. If this happens game over to artificially keep MRP at exorbitant levels by any of the US manufacturers and importers as an inducement to push medical devices sales to hospitals." said Mr. Nath. Of course lobbying forces for high priced  medical devices suppliers will be worried as they will loose the competitive advantage of inducing procurement bodies based on higher margins as the cap becomes a leveller. This will bring back the focus to cost reduction and operational efficiencies by hospitals to remain competitive and profitable.  Let's hope other State Health Ministers follow this lead by Delhi Govt and NPPA and DoP consider this as a possible reform in the regulations for Price Controls of Medical Devices